H. Ishii et al., ANALYSIS OF APOPTOSIS MORPHOLOGY IN EPSTEIN-BARR-VIRUS POSITIVE AND NEGATIVE BURKITTS-LYMPHOMA CELLS, Archives of histology and cytology, 60(2), 1997, pp. 143-152
In recent studies of cycloheximide (CHS)induced apoptosis in sublines
of established Burkitt's lymphoma cell lines (BJA-B) both with and wit
hout Epstein-Barr virus (EBV) infection, we noticed two distinct types
of apoptosis morphology. In the present paper, we have classified the
se, and further carried out a statistical analysis of their incidence
in untreated and CHX-treated EBV-free (EBV(-)) and EBV-infected (EBV()) BJA-B cells. Classification: Both types of apoptosis morphology dem
onstrated typical nuclear and cytoplasmic condensation. However, ''Typ
e 1 apoptotic cells'' (AP1) maintained a spherical or ovoid shape, but
''Type 2 apoptotic cells'' (AP2) were typified by the lobulation of t
heir nuclear and cytoplasmic structures to form ''clover leaf'' shapes
, Statistical analysis of incidence: The numbers of AP1 and AP2 cells
were analysed using a chi(2) test, with results as follows: EBV(-) cel
ls underwent AP1 in preference to AP2 (90.5% versus 9.5%) (p < 0.001),
whilst EBV(+) cells had comparably more AP2, making AP1 and AP2 appro
ximately equal (49.3% versus 50.7%) (p > 0.1). In EBV(-) cells, treatm
ent with CHX had little effect on the ratios of differing apoptotic mo
rphology. In contrast, in the EBV(+) cells, cell death was altered fro
m AP2 (50.7% --> 25.2%) towards AP1 (49.3% --> 74.8%) (p < 0.001). We
propose that cellular proteins known to be associated with EBV infecti
on not only protect the cells from apoptosis, but also affect the phen
otype of apoptosis. This knowledge may be useful for defining possible
mechanisms of apoptosis induction and/or inhibition in specific model
s.